Sprache: Englisch
Verlag: Cambridge University Press, 2022
ISBN 10: 1108718442 ISBN 13: 9781108718448
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
EUR 47,12
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. In.
Sprache: Englisch
Verlag: Cambridge University Press, 2020
ISBN 10: 1108499872 ISBN 13: 9781108499873
Anbieter: Prior Books Ltd, Cheltenham, Vereinigtes Königreich
Erstausgabe
EUR 41,11
Anzahl: 1 verfügbar
In den WarenkorbHardcover. Zustand: Like New. First Edition. A nearly new hardback with just a small hardly noticeable 'damaged' stamp at the prelims. Despite such this book is not showing any defects, just a few very mild rubs and bumps. Thus it looks and feels unread with contents that are chrisp, fresh and tight. Now offered for sale at a reasonable price.
Sprache: Englisch
Verlag: Cambridge University Press, 2022
ISBN 10: 1108718442 ISBN 13: 9781108718448
Anbieter: Kennys Bookstore, Olney, MD, USA
Zustand: New.
Sprache: Englisch
Verlag: Cambridge University Press, 2022
ISBN 10: 1108718442 ISBN 13: 9781108718448
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - The advent of the CRISPR/Cas9 class of genome editing tools is transforming not just science and medicine, but also law. When the genome of germline cells is modified, the modifications could be inherited, with far-reaching effects in time and scale. Legal systems are struggling with keeping up with the CRISPR revolution and both lawyers and scientists are often confused about existing regulations. This book contains an analysis of the national regulatory framework in eighteen selected countries. Written by national legal experts, it includes all major players in bioengineering, plus an analysis of the emerging international standards and a discussion of how international human rights standards should inform national and international regulatory frameworks. The authors propose a set of principles for the regulation of germline engineering, based on international human rights law, that can be the foundation for regulating heritable gene editing both at the level of countries as well as globally.
Sprache: Englisch
Verlag: Cambridge University Press, 2020
ISBN 10: 1108499872 ISBN 13: 9781108499873
Anbieter: Majestic Books, Hounslow, Vereinigtes Königreich
EUR 153,77
Anzahl: 1 verfügbar
In den WarenkorbZustand: New.
Sprache: Englisch
Verlag: Cambridge University Press, 2020
ISBN 10: 1108499872 ISBN 13: 9781108499873
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
EUR 189,83
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. In.
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
EUR 266,29
Anzahl: 2 verfügbar
In den WarenkorbHardcover. Zustand: Brand New. 1st edition. 636 pages. 9.25x6.25x1.75 inches. In Stock.
Sprache: Englisch
Verlag: Cambridge University Press, 2020
ISBN 10: 1108499872 ISBN 13: 9781108499873
Anbieter: Kennys Bookstore, Olney, MD, USA
EUR 277,67
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. 2020. 1st Edition. hardcover. . . . . . Books ship from the US and Ireland.
Sprache: Englisch
Verlag: Cambridge University Press, 2020
ISBN 10: 1108499872 ISBN 13: 9781108499873
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - The advent of the CRISPR/Cas9 class of genome editing tools is transforming not just science and medicine, but also law. When the genome of germline cells is modified, the modifications could be inherited, with far-reaching effects in time and scale. Legal systems are struggling with keeping up with the CRISPR revolution and both lawyers and scientists are often confused about existing regulations. This book contains an analysis of the national regulatory framework in eighteen selected countries. Written by national legal experts, it includes all major players in bioengineering, plus an analysis of the emerging international standards and a discussion of how international human rights standards should inform national and international regulatory frameworks. The authors propose a set of principles for the regulation of germline engineering, based on international human rights law, that can be the foundation for regulating heritable gene editing both at the level of countries as well as globally.